ALLMedicine™ Diabetic Neuropathy Center

Oct 16th, 2021 - Epalrestat, an aldose reductase inhibitor increases PMM enzyme activity in a PMM2-CDG worm-model. Epalrestat also decreases sorbitol level in diabetic neuropathy. We evaluated the genetic, biochemical and clinical characteristics including the Nij...

Oct 14th, 2021 - Diabetes mellitus is one of the most common chronic diseases with a high number of sufferers worldwide. Diabetic neuropathy and diabetic angiopathy lead to serious infectious complications which are very difficult to combat and may finally lead to...

Oct 12th, 2021 - Type 1 diabetes mellitus (DM1), a chronic metabolic disorder of autoimmune origin, has been associated with oxidative stress (OS), which plays a central role in the onset, progression, and long-term complications of DM1. The markers of OS lipid pe...

Oct 9th, 2021 - Autonomic neuropathy is most often associated with advanced diabetes mellitus, either type 1 or type 2. The chronic diabetes complication can occur in various forms and affects the cardiovascular, gastrointestinal, endocrine, and genitourinary sys...

Sep 29th, 2021 - Diabetic neuropathy (DN) is a major complication associated with diabetes mellitus (DM) and results in fatigue. We investigated whether type 2 diabetic patients with or without neuropathy experienced muscle fatigue and determined the most influenc...

Jun 23rd, 2011 - The Cardiovascular Autonomic Neuropathy (CAN) Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy worked to update CAN guidelines, with regard to epidemiology, clinical impact, diagnosis, usefulness of CAN testing, and management. C...

Apr 13th, 2011 - To develop a scientifically sound and clinically relevant evidence-based guideline for the treatment of painful diabetic neuropathy (PDN). We performed a systematic review of the literature from 1960 to August 2008 and classified the studies accor...

Sep 27th, 2021 - There are different types of pain in coccygodynia. Patients may suffer from e somatic, neuropathic or mixed pain.Vitamin D plays an important role in the pathophysiology of pain. Vitamin D inhibits NO synthase (iNOS) in microglia and astrocytes. T...

Sep 14th, 2021 - The sponsor created a new pharmaceutical formulation of CAPSAICIN topical solution applicable in roll-on. This new formulation in roll-on represents a line extension of drug ARAFARMADOL 0.075 cream, which is currently marketed in Spain by the spon...

Sep 14th, 2021 - Study 1.1 Diabetic Neuropathy Screening Study Objective The objective of this study is to investigate the prevalence of diabetic neuropathy at the outpatient clinic of SDCC and to investigate the association between diabetic neuropathy and diabeti...

Aug 9th, 2021 - A randomized controlled trial will be performed with 62 patients with diabetic neuropathy. The participants will be randomly assigned into either a control group (recommended foot care by international consensus with no foot exercises) or an inter...

Jul 15th, 2021 - The purpose of this trial is to investigate the efficacy and safety of GRT6005 in patients with painful diabetic neuropathy.

Jul 21st, 2021 - The Food and Drug Administration has approved the first high-frequency spinal cord stimulation (SCS) therapy for treating painful diabetic neuropathy (PDN). The approval is specific for the treatment of chronic pain associated with PDN using the N...

Jul 19th, 2021 - The FDA approved the first spinal cord stimulation device (HFX) for painful diabetic neuropathy (PDN), Nevro Corp announced on Monday. The device, the only such treatment approved by the agency for this specific indication, delivers high-frequency...

Jul 1st, 2021 - NEW YORK (Reuters Health) - High-frequency (10 kHz) spinal-cord stimulation (SCS) provides lasting pain relief and improved quality of life in patients with painful diabetic neuropathy (PDN) who fail conventional management, according to long-term...

Apr 2nd, 2021 - Transcript:Alice Beers, RN, BSN, OCN: In our practice, the teaching is very extensive. At the cancer center that I work in, it’s our requirement that all patients attend a chemotherapy education class. So, that’s our beginning point, if you will. ...

Feb 15th, 2021 - Prescriptions for opioids as a first-line treatment for painful diabetic peripheral neuropathy (DPN) outnumbered those for other medications between 2014 and 2018, despite the fact that the former is not recommended, new research indicates. "We kn...